Resourceful Insights Related To The Sexually Transmitted Diseases Testing Market Included In The Research Report

-




Sexually transmitted diseases or venereal diseases (VDs) are one of the most critical health challenges facing the world today. Rising rates of incidence of fatal STDs, corresponding high-economic burden and consequent implementation of Provider-Initiated Counselling and Testing (PICT) and Client-Initiated Counselling and Testing (CICT) are factors that drive the growth of the diagnostic testing market for STDs.
STDs are a grave issue globally, and are responsible for high morbidity in adults and cause infertility in both men and women. Complications such as ectopic pregnancy, cervical cancer in women and congenital mortality are observed in patients suffering from STDs. Generally, patients suffering from STDs are observed to be within 15 to 44 years, and ~500 million new cases of STDs are registered per year. Diagnostic procedures of STDs market include the technologies that are used to identify and analyze STD along with the laboratories where the tests are carried out.

 Request a Sample PDF to Evaluate More      


 



Comments

Post a Comment

Popular posts from this blog

Cancer diagnostics market statistics and research analysis released in latest report

-
  A research study conducted by Global Market Insights, Inc., suggests that Cancer Diagnostics Market is likely to exceed the $170 billion mark by 2025, in terms of revenue. Growing awareness regarding early disease diagnosis coupled with increasing number of diagnostic and research laboratories will drive cancer diagnostics market demand over the forthcoming time period. Evolving healthcare infrastructure of developing countries, rising awareness about cancer, and increasing healthcare spending will further influence the market growth positively. With growing prevalence of cancer cases across the globe, key industry players are increasingly focusing on consolidating their position in the market through several tried-and-tested methods. Citing an instance, on 29 th June 2020, BioCare Medical, a renowned provider of automated, innovative, immunohistochemistry (IHC) instrumentation and reagents, reportedly announced a collaborative partnership with Bethyl Laboratories for developing ta
Read more

Laparoscopic Instruments market research report by 2020 to 2026

-
  A research study conducted by Global Market Insights, Inc., suggests that Laparoscopic Instruments market is likely to exceed the $ 20 billion mark by 2026, in terms of revenue. owing to the rising incidence of colorectal cancer. According to reliable estimates, colorectal cancer is the third most common cancer diagnosis with death due to cancer seen in both men and women across industrialized nations. Given the increasing prevalence of cancer cases, the demand for laparoscopic procedures will also increase tremendously, thereby boosting the market growth.   With ongoing technological advancements and new innovations, the laparoscopic instruments market is slated to further witness tremendous growth over the coming years. While robotic surgery is not new in the medical field, new advancements in the field of robotic hardware and software will augment the next gen of tools and instruments that would enhance the skills of physicians and patient outcomes Request for a sample copy o
Read more

Botulinum Toxin industry analysis research and trends report for 2020- 2026

-
A research study conducted by Global Market Insights, Inc., suggests that Botulinum Toxin market is likely to exceed the $8.9 billion mark by 2026, in terms of revenue. Botulinum toxin market trends are likely to be driven by the escalating demand for cosmetic treatment to reduce laxity, facial wrinkles and other non-invasive procedures for beauty enhancement. The pursuit of beauty and youth has undergone a revival of interest as evinced by rise in visits of individuals to cosmetology clinics. Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/3408 The recent approval of the potent botulinum toxin Dysport, which is the first and only FDA approved toxin for the treatment of lower and upper limb spasticity in both pediatrics and adults, will offer several opportunities for the industry players over the coming years. A report suggests that global botulinum toxin market size will cross the USD 8.9 billion mark by 2026. Botulinum toxin A is
Read more